BSGM Stock - BioSig Technologies, Inc.
Unlock GoAI Insights for BSGM
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $40,000 | $18,000 | $286,000 | $441,000 | N/A |
| Gross Profit | $40,000 | $18,000 | $229,000 | $242,000 | $-550,000 |
| Gross Margin | 100.0% | 100.0% | 80.1% | 54.9% | N/A |
| Operating Income | $-12,862,000 | $-28,512,000 | $-27,265,000 | $-33,411,000 | $-59,184,000 |
| Net Income | $-10,330,000 | $-29,041,000 | $-27,271,000 | $-31,362,000 | $-52,174,000 |
| Net Margin | -25825.0% | -161338.9% | -9535.3% | -7111.6% | N/A |
| EPS | $-0.07 | $-0.40 | $-0.63 | $-0.94 | $-1.87 |
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
Visit WebsiteEarnings History & Surprises
BSGMEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 13, 2025 | $-0.04 | $-0.05 | -16.8% | ✗ MISS |
Q3 2025 | Aug 15, 2025 | $-0.04 | $-0.74 | -1750.0% | ✗ MISS |
Q2 2025 | May 19, 2025 | $-0.05 | $-0.14 | -180.0% | ✗ MISS |
Q2 2025 | Apr 15, 2025 | $-0.17 | $-0.03 | +82.4% | ✓ BEAT |
Q4 2024 | Nov 14, 2024 | $-0.20 | $-0.12 | +40.0% | ✓ BEAT |
Q3 2024 | Aug 14, 2024 | $-0.10 | $-0.30 | -200.0% | ✗ MISS |
Q2 2024 | May 20, 2024 | $-0.29 | $-0.36 | -24.1% | ✗ MISS |
Q2 2024 | Apr 16, 2024 | $-0.50 | $-0.82 | -64.0% | ✗ MISS |
Q4 2023 | Nov 14, 2023 | $-0.10 | $-0.60 | -500.0% | ✗ MISS |
Q3 2023 | Aug 14, 2023 | $-0.10 | $-1.60 | -1500.0% | ✗ MISS |
Q2 2023 | May 15, 2023 | $-0.10 | $-0.12 | -20.0% | ✗ MISS |
Q1 2023 | Mar 31, 2023 | $-0.12 | $-1.40 | -1066.7% | ✗ MISS |
Q4 2022 | Nov 14, 2022 | $-1.40 | $-1.40 | 0.0% | = MET |
Q3 2022 | Aug 15, 2022 | $-1.70 | $-1.50 | +11.8% | ✓ BEAT |
Q2 2022 | May 16, 2022 | $-0.18 | $-0.22 | -22.2% | ✗ MISS |
Q1 2022 | Mar 31, 2022 | $-0.22 | $-0.24 | -9.1% | ✗ MISS |
Q4 2021 | Nov 15, 2021 | $-0.23 | $-0.21 | +8.7% | ✓ BEAT |
Q3 2021 | Aug 11, 2021 | $-0.26 | $-2.40 | -823.1% | ✗ MISS |
Q2 2021 | May 17, 2021 | $-0.15 | $-2.60 | -1633.3% | ✗ MISS |
Q1 2021 | Mar 15, 2021 | $-0.43 | $-3.10 | -620.9% | ✗ MISS |
Latest News
Frequently Asked Questions about BSGM
What is BSGM's current stock price?
What is the analyst price target for BSGM?
What sector is BioSig Technologies, Inc. in?
What is BSGM's market cap?
Does BSGM pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to BSGM for comparison